On May 23, 2018, we published revised versions of our Privacy Policy and User Agreements. Please read these updated terms and take some time to understand them. Your use of our services is subject to these revised terms.
Yes, I Agree.
WednesdayFeb 14, 2024 9:00 am

Lexaria Bioscience Corp. (NASDAQ: LEXX) Kicks off 2024 with FDA IND Submission for its HYPER-H23-1 Phase 1b Human Clinical Trial

Lexaria, a global innovator in drug delivery platforms, just announced the submission of its IND application with the FDA for its HYPER-H23-1 phase 1b hypertension clinical trial This study will seek to evaluate the safety and tolerability of Lexaria’s patented DehydraTECH(TM) technology, specifically DehydraTECH-CBD, in hypertensive patients Lexaria expects to build on success of its previous studies, which showed positive results and DehydraTECH-CBD’s potential to have broad therapeutic utility Lexaria Bioscience (NASDAQ: LEXX), a global innovator in drug delivery platforms, just announced the submission of its much-anticipated Investigational New Drug (“IND”) application with the U.S. Food and Drug Administration (“FDA”)…

Continue Reading

TuesdayFeb 13, 2024 4:20 pm

420 with CNW — Judge Rejects Challenge by Out-of-State Residents Against New York’s Cannabis Program

A recent ruling by a federal judge Anne M. Nardacci has dismissed a lawsuit challenging New York’s cannabis licensing program. The lawsuit, filed by two applicants from California, argued that the program unfairly discriminates against non-New York state residents. The ruling would allow the state to grant more licenses, which would have a big effect on a market that is primarily controlled by illegal businesses. According to Nardacci, the public’s interest in allowing legitimately licensed entities to dominate the market outweighs the issues brought up by the plaintiffs. She noted that the plaintiffs-cited dormant Commerce Provision does not apply to…

Continue Reading

MondayFeb 12, 2024 4:20 pm

420 with CNW — Virginia Assembly Committee Approves Cannabis Bill Permitting Sales

A recently amended measure, HB 698, advanced by a Virginia Assembly subcommittee, seeks to permit existing medical cannabis dispensaries and certain small businesses to commence recreational marijuana sales in January next year, with more retailers expected to be licensed by year-end. A medical marijuana operator has to quickly establish six microbusinesses to capitalize on an early launch date. The present form of the law would provide $400,000 in funding to each of these microbusinesses. In turn, microbusiness licenses would require that at least two-thirds of the individuals directly controlling the enterprise meet certain social-equity requirements, with preference going to those…

Continue Reading

MondayFeb 12, 2024 10:15 am

Experts Say New Rules by Israeli Authorities Could Trigger Growth for Marijuana Industry

Last month, Israel’s Ministry of Health implemented rules that would make it easier for physicians to administer medical marijuana to their patients. In a statement, the ministry explained that these changes would improve availability of marijuana, decrease bureaucracy for patients who needed the drug and increase medical autonomy of the physicians. The ministry also noted that emphasis was being placed on affording physicians more discretion to administer medical marijuana in their areas of expertise for a range of indications. Bazelet Group’s Head of business development, Itai Rogel, stated in an email that prior to this change in policy, marijuana was…

Continue Reading

MondayFeb 12, 2024 9:00 am

Lexaria Bioscience Corp.’s (NASDAQ: LEXX) CEO, Chris Bunka, Shares 2023 Company Update and 2024 Roadmap in Annual Letter

Lexaria, a global innovator in drug delivery platforms, just announced ambitious plans for the 2024 calendar year The letter confirms that the 2024 plans have been made possible by significant strides that were made by the company in 2023 Lexaria looks to build on the momentum gained from the previous year, ultimately asserting market dominance and making 2024 its best year yet Lexaria Bioscience (NASDAQ: LEXX), a global innovator in drug delivery platforms, just announced its ambitious plans for the 2024 calendar year. In his annual letter, Chris Bunka, Lexaria’s CEO, noted that this would mark the year that will…

Continue Reading

FridayFeb 09, 2024 4:20 pm

420 with CNW — Texas AG Wants Court to Reverse Cannabis Decriminalization in Five Cities

Texas attorney general Ken Paxton is asking the court to overturn cannabis decriminalization policies passed and implemented in five cities and has vowed to overrule the “pro-crime extremists” who championed cannabis reform in the Texas cities. The Republican filed suits against the cities of San Marcos, Austin, Denton, Killeen and Elgin earlier this week to overturn their voter-passed cannabis decriminalization measures. In the filings, Paxton cited relevant state constitutional and statute provisions and argued that these provisions prevented local governments from approving policies that were in conflict with state law. The AG also issued a press release stating that he…

Continue Reading

FridayFeb 09, 2024 9:30 am

Marijuana Officials Want Minnesota Lawmakers to Authorize Temporary Industry Licenses

Marijuana officials in the state of Minnesota are urging lawmakers to consider amendments to licensing processes to help meet its retail cannabis sales goals. Charlene Briner, the interim director of the Office of Cannabis Management, stated in a recent webinar that the agency was focused on hiring staff and building infrastructure needed to oversee the legal marijuana marketplace. Regulators plan to test how efficient an online license application system designed for businesses works in the spring. Briner also revealed that she was hopeful that when legislators resumed their legislative session, they would amend the law to allow for a successful…

Continue Reading

ThursdayFeb 08, 2024 4:20 pm

420 with CNW — Senate Democrats Implore Feds to Remove Marijuana from CSA

In a recent letter to the U.S. Drug Enforcement Administration (DEA), 12 Senate Democrat legislators have urged President Joseph Biden’s administration to reconsider federal cannabis restrictions as the agency contemplates cannabis rescheduling. The letter, signed by the Senate Majority Leader and spearheaded by Senators Elizabeth Warren and John Fetterman, highlights the strong argument in favor of taking cannabis out of Schedule I. The senators suggest removing it completely from the CSA in addition to downgrading its classification. In August 2023, the U.S. Department of Health and Human Services (HSS) recommended moving marijuana from Schedule I to III of the Controlled…

Continue Reading

WednesdayFeb 07, 2024 4:20 pm

420 with CNW — Officials Say Marijuana Dispute Possibly Linked to Six Fatalities in California

Officials believe the recent California desert killings may have resulted from a dispute over cannabis. After responding to a wellness check request outside the El Mirage community, San Bernardino County Sheriff’s deputies recently discovered the bodies of six individuals at a remote dirt crossroad in the Mojave Desert. Deputies found the victims in and near two vehicles at a remote intersection after one of the victims called the police and said that he had been shot but didn’t know his location. After tracking the victim’s phone’s location, deputies discovered five bodies in a Chevy Trailblazer and a Dodge Caravan as…

Continue Reading

WednesdayFeb 07, 2024 1:30 pm

Florida Legislative Committee Passes Preemptive Bill Capping Adult-Use Cannabis Potency

Legislators on the House Healthcare Regulation Subcommittee recently approved a resolution that would impose a THC cap on adult-use marijuana products. THC (tetrahydrocannabinol) is one of the two primary compounds found in marijuana, with the other being CBD (cannabidiol). However, unlike THC, CBD doesn’t induce a high when ingested. The approved resolution, HB 1269, contains an amendment that increased the proposed limit on THC for cannabis flower from 10% to 30%. Representative Ralph Massullo, who introduced the resolution, stated that his proposed cap on THC was based on the fact that not much was known on the potential long-term harms…

Continue Reading

Official NewsWire Relationships

Alternative Products Expo Benzinga Cannabis Capital Conference Cannabis Business Summit & Expo 2019 Cannabis Drinks Expo Cannabis World Congress & Business Exposition Cannexpo Marigold PR MjMicro Conference New England Cannabis Network O'Cannabiz Conference & Expo Tether BudTender Tether BudTender Appreciation Week

CannabisNewsWire Currently Accepts

Bitcoin

Bitcoin

Bitcoin Cash

Bitcoin Cash

Doge Coin

Dogecoin

Ethereum

Ethereum

Litecoin

Litecoin

USD Coin

USD Coin

Contact us: 303.498.7722